OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
CPXG59

Capsensixx AG

Investment Management & Fund OperatorsVerified

Capsensixx AG maintains a conservative capital structure with a debt-to-equity ratio of 0.28, indicating a low reliance on debt financing relative to equity. The company's liquidity position is characterized by EUR 18.5 million in cash and equivalents, which is a significant portion of its total equity of EUR 15.7 million, suggesting strong short-term liquidity. The operating cash flow of EUR 10.5 million further supports its ability to fund operations and potentially reinvest in growth opportunities. In terms of profitability, Capsensixx AG's operating cash flow of EUR 10.5 million reflects its ability to generate cash from operations, which is a key indicator of its financial health. However, the company's profitability metrics should be compared against the industry_config preferred metrics for the Investment Management & Fund Operators sector to assess its relative performance. The company's capital expenditure of EUR -416,000 indicates a reduction in capital spending, which may suggest a focus on maintaining rather than expanding its asset base. The company's revenue is primarily derived from its Fund Admin and Securitization segments, with a significant portion of its operations concentrated in Germany and Luxembourg. The geographic exposure is limited to these regions, which may present both opportunities and risks depending on the economic conditions in these markets. The company's investment in start-up companies in digitization and IT services adds a layer of diversification but also introduces exposure to the volatility of early-stage ventures. Looking at the growth trajectory, Capsensixx AG's revenue of EUR 200.7 million in the latest period suggests a stable revenue base. The company's capital expenditure and operating cash flow indicate a focus on maintaining operational efficiency rather than aggressive expansion. The outlook for the next fiscal year will depend on the performance of its core segments and the success of its investments in start-up companies. The risk assessment for Capsensixx AG indicates a low liquidity risk, supported by its strong cash reserves and low debt levels. The dilution risk is also low, with no immediate filing-based flags detected. The company's conservative capital structure and strong liquidity position reduce the likelihood of near-term dilution pressures. The absence of significant dilution sources in recent filings suggests that the company is not currently under pressure to raise additional capital through equity issuance. Recent events, including the company's focus on maintaining its capital structure and its investments in start-up companies, highlight its strategic direction. The company's financial filings and transcripts do not indicate any immediate concerns regarding liquidity or dilution, which supports the low risk ratings assigned. The company's continued investment in digitization and IT services may also influence its future growth and risk profile.

30-day price · CPXG+0.40 (+1.8%)
Low$22.00High$23.60Close$22.40As of17 May, 00:00 UTC
Profile
CompanyCapsensixx AG
TickerCPXG.F
SectorFinancials
BusinessBanking & Investment Services
Industry groupBanking & Investment Services
IndustryInvestment Management & Fund Operators
AI analysis

Business. Capsensixx AG is a Germany-based holding company engaged in the financial sector, offering fund management, administration, and capital markets services through its subsidiaries, and investing in start-up companies in digitization and IT services.

Classification. Capsensixx AG is classified under the industry "Investment Management & Fund Operators" within the "Banking & Investment Services" business sector, with a confidence level of 0.92.

Capsensixx AG maintains a conservative capital structure with a debt-to-equity ratio of 0.28, indicating a low reliance on debt financing relative to equity. The company's liquidity position is characterized by EUR 18.5 million in cash and equivalents, which is a significant portion of its total equity of EUR 15.7 million, suggesting strong short-term liquidity. The operating cash flow of EUR 10.5 million further supports its ability to fund operations and potentially reinvest in growth opportunities. In terms of profitability, Capsensixx AG's operating cash flow of EUR 10.5 million reflects its ability to generate cash from operations, which is a key indicator of its financial health. However, the company's profitability metrics should be compared against the industry_config preferred metrics for the Investment Management & Fund Operators sector to assess its relative performance. The company's capital expenditure of EUR -416,000 indicates a reduction in capital spending, which may suggest a focus on maintaining rather than expanding its asset base. The company's revenue is primarily derived from its Fund Admin and Securitization segments, with a significant portion of its operations concentrated in Germany and Luxembourg. The geographic exposure is limited to these regions, which may present both opportunities and risks depending on the economic conditions in these markets. The company's investment in start-up companies in digitization and IT services adds a layer of diversification but also introduces exposure to the volatility of early-stage ventures. Looking at the growth trajectory, Capsensixx AG's revenue of EUR 200.7 million in the latest period suggests a stable revenue base. The company's capital expenditure and operating cash flow indicate a focus on maintaining operational efficiency rather than aggressive expansion. The outlook for the next fiscal year will depend on the performance of its core segments and the success of its investments in start-up companies. The risk assessment for Capsensixx AG indicates a low liquidity risk, supported by its strong cash reserves and low debt levels. The dilution risk is also low, with no immediate filing-based flags detected. The company's conservative capital structure and strong liquidity position reduce the likelihood of near-term dilution pressures. The absence of significant dilution sources in recent filings suggests that the company is not currently under pressure to raise additional capital through equity issuance. Recent events, including the company's focus on maintaining its capital structure and its investments in start-up companies, highlight its strategic direction. The company's financial filings and transcripts do not indicate any immediate concerns regarding liquidity or dilution, which supports the low risk ratings assigned. The company's continued investment in digitization and IT services may also influence its future growth and risk profile.
Key takeaways
  • Capsensixx AG maintains a conservative capital structure with a low debt-to-equity ratio of 0.28.
  • The company's liquidity position is strong, supported by EUR 18.5 million in cash and equivalents.
  • Revenue is primarily derived from its Fund Admin and Securitization segments, with a geographic focus on Germany and Luxembourg.
  • The company's growth trajectory is stable, with a focus on maintaining operational efficiency rather than aggressive expansion.
  • Capsensixx AG has a low liquidity and dilution risk, with no immediate filing-based flags detected.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyEUR
Revenue$200.7M
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow$10.5M
CapEx-$416.0k
Free cash flow
Total assets
Total liabilities$63.6M
Total equity$15.7M
Cash & equivalents$18.5M
Long-term debt$4.3M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash$14.2M
Current ratio
Debt/Equity0.3
ROA
ROE
Cash conversion
CapEx/Revenue-0.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Banking & Investment Services · cohort 10 companies
MetricCPXGActivity
Op margin26.6% medp25 13.9% · p75 29.0%
Net margin18.8% medp25 13.7% · p75 22.7%
Gross margin67.6% medp25 41.5% · p75 93.2%
CapEx / revenue-0.2%1.2% medp25 0.4% · p75 1.9%bottom quartile
Debt / equity28.0%7.7% medp25 7.7% · p75 7.7%top quartile
Observations
IR observations
Last actual EPS0.66 EUR
Last actual revenue110,309,000 EUR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 07:01 UTC#1dda50f5
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 07:04 UTCJob: a2630574